Suscribirse

Calcium Phosphate Cement loaded with 10% vancomycin delivering high early and late local antibiotic concentration in vitro - 23/11/18

Doi : 10.1016/j.otsr.2018.07.007 
Gaoyang Chen a, 1, Bo Liu c, 1, He Liu a, Hanyang Zhang a, Kerong Yang a, Qingyu Wang a, Jianxun Ding b, Fei Chang a,
a Department of orthopaedic surgery, 2nd Hospital of Jilin University, No. 218, Ziqiang street, Nanguan District, Changchun 130041, China 
b Key laboratory of polymer ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China 
c Department of orthopaedic surgery, the First Hospital of Jilin University, Changchun, China 

Corresponding author at: department of orthopaedic surgery, 2nd Hospital of Jilin University, No. 218, Ziqiang street, Nanguan District, Changchun 130041, China.department of orthopaedic surgery, 2nd Hospital of Jilin UniversityNo. 218, Ziqiang street, Nanguan DistrictChangchun 130041China

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Antibiotics impregnated calcium phosphate cement (CPC) has emerged as a local treatment of osteomyelitis. However, there is no study investigating the optimal concentrations of vancomycin (VCM) included in CPC to obtain prolonged drug release (≥8 weeks) and also with enough compressive strength (>the normal cancellous bone, 11MPa) for osteomyelitis therapy. Therefore, we bring forward two questions: 1) Was antibiotic activity of the eluates correlated to the load of antibiotics within the cement? 2) Were the mechanical properties of CPC affected by VCM-loading?

Hypothesized

There was an optimal concentrations of vancomycin (VCM) loaded in CPC which could provide sufficient effective antibacterial time (≥8 weeks) and enough compressive strength (>11MPa).

Materials and methods

CPC specimens were obtained by incorporating different doses (weigh ratios of 0%, 5%, 10%, 15%, 20%, 25 and 30%) of injectable VCM into CPC. The antibacterial effect of released VCM solution against Staphylococcus aureus was assessed by inhibition ring assays. The physicochemical properties such as compressive strengths were characterized and compared among these specimens.

Results

Drug release profiles showed only 5 and 10% VCM-loaded CPC displayed a long enough drug release time (at least 8 weeks) and maintained the eluate concentrations (>4μg/mL) with effective antibacterial ability. The concentration of VCM in 10% group at 8th week was twice higher than 5% group. Compressive strength test showed that the proportional increase of VCM/CPC ratios resulted in a significant decrease of compressive strength (r=−0.906, p<0.001).

Conclusion

10% VCM-loaded CPC offered the optimal physicochemical properties and drug releasing profile and appears as the most suitable concentration for clinical use.

Level of evidence

III.

El texto completo de este artículo está disponible en PDF.

Keywords : Calcium phosphate cement, Vancomycin, Osteomyelitis therapy, Mechanical strength


Esquema


© 2018  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 104 - N° 8

P. 1271-1275 - décembre 2018 Regresar al número
Artículo precedente Artículo precedente
  • Impact of setting up a bone and joint infection referral center on arthroscopic treatment of septic arthritis of the knee and shoulder: Retrospective study
  • Marion Besnard, Damien Babusiaux, Pascal Garaud, Philippe Rosset, Louis Bernard, Louis-Romé Le Nail, Julien Berhouet, Orthopedics and Traumatology Society of Western France (SOO) c
| Artículo siguiente Artículo siguiente
  • The best knot and suture configurations for high-strength suture material. An in vitro biomechanical study
  • Dominik C. Meyer, Elias Bachmann, Alexandre Lädermann, Georg Lajtai, Thorsten Jentzsch

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.